19
May
2026
Biotech in the Balance: Saving a Strategic Industry. Jeremy Levin on The Long Run
Jeremy Levin is today’s guest on The Long Run. He is the executive chairman and founder of New York-based Ovid Therapeutics. He’s also a board member of the Biotechnology Innovation Organization, and a past chairman of the BIO board of directors. Jeremy has a new book out today, called “Biotech in the Balance: Saving a Strategic Industry in an Age... Read More
